ITCI: intracellulartherapies.com Market Capitalization

The historical price chart for Intra-Cellular Therapies (ITCI) reflects the dynamics of an asset whose R&D potential is currently peaking as it prepares to expand the application of Caplyta for depression. Market capitalization stands at 14.00, while the business relies on stable, non-cyclical demand within the psychiatry sector. Strong positioning is secured by rigorous patent protection and physician trust, which effectively curbs the expansion of new market entrants.

Intra-Cellular Therapies Inc. - ITCI Market Capitalization (period 07/04/2022 - 04/13/2025)

ITCI (intracellulartherapies.com): analytical breakdowns and indicator data

- stock price and consensus target price:

Stock Quotes Intra-Cellular Therapies, Inc.|ITCI - Analyst Forecast Prices

- market capitalization information:

Market Capitalization Intra-Cellular Therapies, Inc.|ITCI - Real Price to Acquire Entire Company

- issuer book value statistics:

Book Value per Share Intra-Cellular Therapies|ITCI - Book Valuation of Business|Market Value to Book Value Ratio intracellulartherapies.com|ITCI - Total Business Assets

- debt level and financial liquidity data:

Total Debt to Capital Intra-Cellular Therapies|ITCI - Long-Term Liabilities to Capital|Short-Term Debt to Equity Ratio Intra-Cellular Therapies, Inc.|ITCI - Company Aggregate Debts|Debt to Book Capitalization Ratio Intra-Cellular Therapies, Inc.|ITCI - Company Long-Term Loans and Borrowings|Company Short-Term Debt Intra-Cellular Therapies|Quick Ratio intracellulartherapies.com

- financial results and valuation multiples details:

ITCI - Net Financial Result|Expected Profit Intra-Cellular Therapies|ITCI - Price to Earnings Multiple|Projected Price to Earnings Intra-Cellular Therapies, Inc.|ITCI - Company Value to Earnings Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Intra-Cellular Therapies, Inc.|ITCI - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Intra-Cellular Therapies|ITCI - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months intracellulartherapies.com|ITCI - Net earnings per share change in current year|Earnings growth forecast for next year Intra-Cellular Therapies

Fundamental company analysis:ITCI (Intra-Cellular)

Product sample of Intra-Cellular Therapies Inc.

The market capitalization of Intra-Cellular Therapies (ITCI) reflects the aggregate value of all shares, assessing the potential of its molecular platform in psychiatry. This metric is calculated as the product of the current share price and the total number of outstanding securities. By analyzing the company's market capitalization, an investor can discern the market consensus regarding the commercial success of Caplyta. This chart's price action smooths out short-term speculation, revealing a sustainable valuation trend. Avoid buying at local peaks to prevent capital from being locked up.

Key competitors